Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence

Information

  • Research Project
  • 10232130
  • ApplicationId
    10232130
  • Core Project Number
    U24CA228550
  • Full Project Number
    5U24CA228550-05
  • Serial Number
    228550
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/25/2017 - 7 years ago
  • Project End Date
    8/31/2022 - 2 years ago
  • Program Officer Name
    YASSIN, RIHAB R
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    8/6/2021 - 3 years ago
Organizations

Patient-Matched Stem Cells of the Barrett's-Dysplasia-Adenocarcinoma Sequence

The absence of reliable, patient-specific models in cancer biology has been a chronic impediment to understanding heterogeneity, progression, metastasis, and chemotherapy resistance. Recent advances in technologies for cloning adult stem cells resident in normal, regenerative epithelia have been adapted to cloning stem cells from Barrett's esophagus. Investigators in the proposed Center have now extended this technology, in preliminary studies, to cloning the stem cells of dysplastic Barrett's and adenocarcinoma itself. The impact of this technology for resolving key questions in Barrett's and cancer biology in general, including the precise steps in tumorigenesis from precursor lesions, the functional and genomic intra-tumor heterogeneity and its impact on chemotherapy resistance, and lastly the nature and targetability of stem cells of precursor lesions and frank adenocarcinoma, is potentially transformative. As potentially transformative is a biorepository that exploits the regenerative and clonal nature of these stem cells to extend our knowledge of discrete cases in parallel fashion. In Aim 1, we will generate high-density arrays of stem cell clones corresponding to a topological sampling across four mucosal resections of patients with early adenocarcinoma. Aim 2 will generate large libraries of cancer stem cells from advanced cases of esophageal adenocarcinoma. Aim 3 will generate an interactive database that links datasets from both the arrays of clones derived from mucosal resections as well as those associated with analyses of the cancer stem cell libraries. We anticipate that such a virtual database of datasets would greatly augment downstream studies with the same libraries and discrete clones as each would come with such linked datasets that would be further extended by ongoing and future studies by investigators within the Center and across the community.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    U24
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    117647
  • Indirect Cost Amount
    62353
  • Total Cost
    180000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    396
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NCI:180000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF HOUSTON
  • Organization Department
    BIOLOGY
  • Organization DUNS
    036837920
  • Organization City
    HOUSTON
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    772042610
  • Organization District
    UNITED STATES